Comparing the Nautilus NeuroWaveTM to TCD or DSA for the Detection of Vasospasm

NCT02071875 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2022-07-01

No results posted yet for this study

Summary

To determine the efficacy of using the Jan Medical NNW system as a diagnostic aid in detection of moderate and severe vasospasm for detection of vasospasm in patients with subarachnoid hemorrhage.

Conditions

  • Vasospasm

Interventions

DEVICE

Nautilus NeuroWaveTM recording

Nautilus NeuroWaveTM recording 15 minute recording with Nautilus NeuroWave Neurodiagnostic .

Sponsors & Collaborators

  • Jan Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Axel Neulen, MD · University Medical Center of the Johannes Gutenberg University Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02071875 on ClinicalTrials.gov